about
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportAutoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significancePlasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinomaDiagnosis of pernicious anemia and the risk of pancreatic cancerReview article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.Skin cancers associated with autoimmune conditions among elderly adults.Review article: gastrin and colorectal cancer.Subacute combined degeneration one century later. The neurotrophic action of cobalamin (vitamin B12) revisited.Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans.Pernicious anemia and subsequent cancer. A population-based cohort study.Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders.Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies.Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia.Pernicious anaemia and cancer risk in Denmark.Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression.Cancer Risk After Pernicious Anemia in the US Elderly Population.Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.Achlorhydria is associated with gastric microbial overgrowth and development of cancer: lessons learned from the gastrin knockout mouse.Benzene-induced acute myeloid leukemia: a clinician's perspective.Autoimmune gastritis mediated by CD4+ T cells promotes the development of gastric cancer.The consequences of hypergastrinemia.Population-based study of autoimmune conditions and the risk of specific lymphoid malignanciesVagotomy and Gastric TumorigenesisSystematic review: gastric cancer incidence in pernicious anaemia.Proton pump inhibitors and the risk of colorectal cancer.The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth.Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis.Effects of acid suppression on microbial flora of upper gut.Pathophysiological effects of long-term acid suppression in man.Gastric cancer. Update on diagnosis, staging, and therapy.Gastrin, gastrin receptors and colorectal carcinoma.Alternative therapeutic options in patients with advanced gastrointestinal cancer.Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa.Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-alpha.Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis.Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome.Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
P2860
Q24674636-762F4908-0CF3-49F8-BB0D-EF62CEB268C6Q26743454-6DD7A482-20C9-442B-B1F0-B4363E1F5578Q28345115-B32A6D57-BBE7-478F-B9C8-F59170A60FFAQ33586606-9394BED8-92DA-4A8F-8317-9336E4F930E3Q33940198-3E2F3BA1-C18E-4002-8DFF-39793C56D146Q33952562-26C2CA10-C0CA-4226-A351-1BF73C2D20DEQ34049799-4ED8AD0C-1F57-49B7-BB5C-4CED7F871CA1Q34197977-7D68B844-D57A-4DE3-B326-1F9EC9245C75Q34396057-4D35E404-7FE5-4617-B58A-74F1406B7B11Q34526439-D535B91A-65C7-4BC6-98CC-9152AA5D18E4Q34642920-B926A17E-DFC0-46BD-931F-D8DB1170084DQ34730357-0419C096-0673-49DB-B543-2369F7A2FF0CQ35104427-66A5A861-E918-4D86-AE99-CEA6746563F9Q35120199-20428470-5913-4993-9CF2-87D050954521Q35595806-79638541-E273-4C56-9FCF-39ECF59CA40BQ36138673-C907593A-2D32-4BA0-B390-66273BA388CCQ36190380-8A83C1E0-0254-466F-8569-6A594178B914Q36304871-17A112C6-8165-4CA4-95D3-E28AD2A5F625Q36376528-B1208335-1563-4352-8449-3E4E97791367Q36508844-C442EF9C-3A11-4BE9-81A6-73B98CC2AA24Q36652560-DC36EE86-FE8F-4563-B8A9-B5A757E328D5Q36823934-4E55FCDC-AE85-49C9-ADA7-FCF6FB7EC047Q36839442-894E7A11-E0DD-493B-8F62-BBD63A7FCFAFQ36987482-99F11F19-A190-4C48-A6FD-F15557D86CC3Q37218079-B621C1A4-D5AF-4B2C-8BF7-F553BD894248Q37677019-824B1E5F-39C6-4F8F-9DAE-7459D3F71D02Q38065290-125F9322-173F-4011-B3AB-B6C5C47C5FCBQ38459132-153D4738-5533-4845-8C01-F86BF2ACBB5DQ40548301-FFD0CC7E-E12F-4492-8756-4AF301672E74Q40595580-B519636F-8286-494B-82B3-B2084CEA5D53Q40595590-A9ECF3B3-44E2-47A6-BEC8-4ED6D2A2F93AQ40595597-B43BCAA3-EB42-4C10-B322-4A39D2C5A465Q41615521-4155A1AF-90B9-4190-A6D4-6B808E4678C2Q41998447-3C659F16-5B0B-4F48-A527-5D7826265466Q42590309-7729A3EA-25C6-4504-8075-8A77A9F4BF71Q43824403-986CAD65-BE0A-4749-8600-055E83B384F9Q46650017-2B69FE30-8517-42A1-AD65-0635E501FE67Q46750544-050712DB-CCD7-49D6-8C00-5677980D3A16Q51034919-5180A435-1E4B-4CB8-B15B-9765F18AB556Q51825278-F500B3C8-96EC-4341-9FAC-8D28FA00BD79
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Cancer risk following pernicious anaemia.
@ast
Cancer risk following pernicious anaemia.
@en
type
label
Cancer risk following pernicious anaemia.
@ast
Cancer risk following pernicious anaemia.
@en
prefLabel
Cancer risk following pernicious anaemia.
@ast
Cancer risk following pernicious anaemia.
@en
P2093
P2860
P356
P1476
Cancer risk following pernicious anaemia.
@en
P2093
Fraumeni JF Jr
P2860
P2888
P304
P356
10.1038/BJC.1989.169
P407
P577
1989-05-01T00:00:00Z